Status
Conditions
Treatments
About
The aim of this study is to assess the relationship between adenomyosis/myoma and lower urinary tract symptoms, sexual function and gastrointestinal symptoms.
Full description
All outpatient patients were found to have >3 cm uterine myoma or adenomyosis were invited to participate in this study. The size and location of uterine myoma or adenomyosis and the uterus should be assessed by ultrasonography. Besides, all enrolled female patients will be asked to complete overactive bladder symptom score, female bladder function (UDI-6 & IIQ-7), female sexual function index, and bowel incontinence assessment questionnaires. In addition, patients who underwent surgeries for myoma or adenomyosis will be requested to complete the above questionnaires at 3 months after surgery. Women with intact uterus should be assessed again by ultrasonography. At least 30 women with age and body mass index matched and without uterine myoma or adenomyosis will be invited to participate in this study as the control group.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
<Women with myoma or adenomyosis>
Inclusion Criteria:
<The control group>
Inclusion criteria:
<Both groups>
Exclusion Criteria:
150 participants in 3 patient groups
Loading...
Central trial contact
Sheng-Mou Hsiao, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal